drugset / Trial / NCT03536208
Biological Effect of Warfarin on Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
This study aims to asses the effect of warfarin on markers of AXL pathway in patients with pancreatic adenocarcinoma.
Timeline
- Start
- 2019-05-15
- Primary completion
- 2021-06
- Completion
- 2022-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Warfarin | Small molecule | 1 mg | Oral |
| Subject | Warfarin | Small molecule | 2 mg | Oral |
| Subject | Warfarin | Small molecule | 2.5 mg | Oral |
| Subject | Warfarin | Small molecule | 4 mg | Oral |
| Subject | Warfarin | Small molecule | 5 mg | Oral |